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Abstract
This work investigated polyethyleneimine (PEI)-introduced chitosan (CS) (CS/PEI) nanoparticles as non-
viral carrier of plasmid DNA for rat mesenchymal stem cells (MSCs). The CS/PEI nanoparticles were
prepared by the emulsifier-free emulsion polymerization of methyl methacrylate monomer induced by
a small amount of t-butyl hydroperxide in the presence of different concentrations of PEI mixed with CS.
The resulting nanoparticles were characterized by their surface properties and buffering capacity. In vitro
gene transfection was also evaluated. The introduction of PEI affected the surface charge, dispersing stabil-
ity and buffering capacity of the nanoparticles. The CS/PEI nanoparticles formed a complex upon mixing
with a plasmid DNA of luciferase. The complex enhanced the level of gene transfection and prolonged the
time period of expression for MSCs, compared with those of plasmid DNA–original CS and PEI nanoparti-
cles. Cytotoxicity of CS/PEI complexes with plasmid DNA was significantly low, depending on the amount
of PEI introduced. It is concluded that the CS/PEI nanoparticle was a promising carrier for gene delivery of
MSCs.
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1. Introduction
Mesenchymal stem cells (MSCs) have the potential to induce the regeneration
of mesenchymal tissues, such as bone, cartilage, muscle, ligament, tendon, adi-
pose and marrow stroma tissues. The cells can be differentiated effectively into
the adipocytic, chondrocytic, or osteocytic lineages [1–3]. Based on the biologi-
cal aspects, MSC-based therapy is one of the promising approaches to achieve the
regeneration and repairing of tissues [4–11]. It is expected for more effective cell
therapy to use MSC genetically modified for the functional activation. For example,
Meinel et al. studied the cell therapy of human MSC genetically engineered with
adenovirus, containing a human BMP-2 gene in the combination with silk scaffold
[12]. Ahn et al. examined PEI as a carrier of gene transfection for human adipose
tissue-derived stem cells [13]. Uludag and co-workers reported the effectiveness of
an amphiphilic poly(L-lysine)-palmitic acid in the plasmid DNA carrier for bone
marrow stromal cells [14]. Moreover, Hosseinkami et al. have prepared cationized
polysaccharides for a non-viral gene carrier to enhance the DNA expression of MSC
[15] and demonstrated the therapeutic efficacy in acute cardiac infarction [16].
To effectively transfect cells, various viral and non-viral carriers have been ex-
tensively investigated. Compared with the viral carrier, although a non-viral one is
less effective in term of gene transfection, it has superior safety profiles and low im-
munogenicity. Therefore, it a great challenge to develop effective non-viral carriers
for successful gene therapy.
Among the non-viral carriers, cationic polymers have attracted great attention,
since they can complex with plasmid DNA through the electrostatic interaction.
Moreover, their properties can easily be modified by changing the constituents
of monomer, controlling the polymerization conditions, or chemically introduc-
ing functional groups to the polymers. In addition, the composition can be easily
manipulated by the conjugation with a targeting ligand or intracellular trafficking
enhancer [17]. Polyethyleneimine (PEI) is one of the most promising non-viral
carriers because it shows a proton sponge effect [18]. However, for the clinical
application, PEI has some problems to be resolved, such as its biodegradability and
toxicity. Consider on biodegradability and toxicity, much attention has been given
to chitosan (CS), since it possesses interesting properties such as biocompatibil-
ity, biodegradability, film forming ability, gelation characteristics, and bioadhesion.
Moreover, because of its polycationic nature, CS has been extensively investigated
for carrier and delivery systems of negatively charged agents. CS is also a good
candidate for a plasmid DNA carrier that has been extensively investigated, but the
transfection efficiency is still low. It has been reported that the low ability of gene
transfection is due to the instability of CS–DNA complexes, which results in the
aggregation at the outside of cell membrane, and, consequently, poor cellular inter-
nalization [19]. Moreover, no buffering effect necessary for the endosomal escape
of complex is another disadvantage [20–22]. It is practically necessary to develop
a new non-viral carrier of gene transfection by combining the material advantage
of PEI and CS.
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In this study, CS/PEI nanoparticles were prepared by an emulsifier-free emul-
sion polymerization in the presence of PEI and chitosan. The PEI/CS weight ratio
in preparation was changed systematically to evaluate the effect on particle size,
surface charge and buffering capacity. Following the incubation with MSCs, the
level of gene expression and the expression period were evaluated and compared
with those of CS and PEI nanoparticles.
2. Materials and Methods
2.1. Materials
CS was purchased from Seafresh Chitosan Lab. (Thailand). The degree of deacety-
lation was ca. 85%, and the weight-average molecular weight of CS was ca.
45 × 103, determined by a viscometric method. Branch polyethyleneimine (PEI;
molecular weight 750 × 103) was purchased from Aldrich. Methyl methacrylate
(MMA) and t-butyl hydroperoxide (TBHP) were purchased from Fluka. TBHP was
used as obtained. MMA was purified to remove inhibitors using a column packed
with alumina adsorbent. PEI was diluted with deionized water to 10 wt% and care-
fully adjusted with HCl until the pH 7. Deionized (DI) and autoclaved water were
sterilized and used throughout the study. All other chemicals were commercially
available and of analytical grade.
2.2. Methods
2.2.1. Preparation of PEI-Introduced Chitosan Nanoparticles
The emulsifier-free emulsion polymerization was carried out by the aid of the
amine/TBHP initiating system as illustrated in Fig. 1. Both PEI and chitosan have
plenty of amine groups on their backbones capable of forming initiating system
with TBHP. The resulting radicals on the nitrogen atoms of amines were then
propagated with vinyl monomers. By using this polymerization method, core–shell
nanoparticles can be formed with PEI and chitosan as a shell and vinyl polymer as
a core [23]. The synthetic procedure was briefly described as follows: The poly-
merization was conducted in a 100-ml water-jacketed glass reactor equipped with a
reflux condenser, nitrogen inlet, thermostat water bath, and magnetic stirrer. A to-
tal reaction volume of 50 ml was generally used. CS (0.5 g), predissolved in 1%
acetic acid, and deionized water were mixed with PEI (10 wt%, pH 7) solution. The
weight ratio of CS to PEI was varied (0.5:0, 0.5:0.1, 0.5:0.3, 0.5:0.5 and 0:0.5). The
mixture was purged with nitrogen gas for 30 min. Water was pumped through the
jacketed reactor from a thermostat water bath, which was controlled at 80 ± 1◦C.
The MMA monomer (1 g) was added, followed by an addition of TBHP aqueous
solution (1 g, 5 × 10−3 M) to initiate polymerization. Then, the polymerization
was continued for 2 h under nitrogen atmosphere. The homopolymer and unreacted
monomer were removed by Soxhlet extraction.
2.2.2. Determination of Monomer Conversion and Solid Content
The monomer conversion and solid content were determined gravimetrically. About
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Figure 1. Scheme of emulsifier-free emulsion polymerization in the presence of different concentra-
tions of PEI mixed with CS under N2 atmosphere at 80◦C for 2 h for CS/PEI nanoparticles preparation.
2 g nanoparticle latex prepared was taken into a pre-weighed aluminum pan. Af-
ter complete evaporation in a fume-hood, the air-dried latex was further dried in
a vacuum oven at 70◦C. The monomer conversion was calculated from the weight




Weight of dried latex − Weight of PEI and/or CS used
Weight of monomer feed
)
× 100,
Solid content (%) =
(





The hydrodynamic diameter and polydispersity index (PDI) of nanoparticles were
measured using a dynamic light scattering (DLS) method with a laser particle size
analyzer (Malvern Instruments, UK) at 25◦C. Then, the latex samples were dropped
into the sample chamber with continuous stirring until the suitable concentration
was attained, which was in the range of 1–5 wt%. The measurements were repeated
three times. The surface charge of nanoparticles was measured by electrophoretic
light scattering (ELS), using a zetasizer (NanoZS 4700, Malvern Instruments) in
1 mM NaCl solution at room temperature. The measurements were done at a wave-
length of 633 nm at 25◦C with a scattering angle of 90◦. The results reported were
the mean of three determinations. The morphology of nanoparticles was observed
with scanning electron microscope (SEM, S-2500, Hitachi, Japan). To prepare the
sample, 50 µl nanoparticle (10 mg/ml) dispersion was dropped on a cover glass and
dried in a dust-free environment. The dried specimens were stuck on the sample
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holders with a double-coated carbon conductive tab and then were sputter-coated
under vacuum with platinum and palladium by using a sputter coater (E-102, Hi-
tachi, Japan). The sputter-coated sample was observed by the microscope at 15 eV.
Fourier-transform infrared (FT-IR) spectroscopy was used to confirm the grafting
reaction of PMMA onto chitosan-PEI mixture. The dried nanoparticles were first
extracted with dichloromethane for 2 days to separate the homo-PMMA to obtain
the pure CS/PEI. FT-IR spectra of the samples were recorded in the attenuated total
reflection mode using an FT-IR spectrophotometer (Equinox 55, Bruker) equipped
with a single reflection ATR unit. The powder samples were pressed in contact be-
tween the internal reflection element (IRE) crystal and the gripper plate. The spectra
were recorded at a resolution of 4 cm−1 and 32 scans. Each spectra scanning was
done in the range between 4000 and 600 cm−1. The weight fraction of PEI in the
particles was obtained from the examination of FT-IR absorption intensity, by com-
paring the intensity of the signal at 1635 cm−1 (NH stretching from both CS and
PEI) to that at 1546 cm−1 (NH complexed with acetic acid found in CS only). The
standard calibration curve was first established by plotting the intensity ratio of the
above the FT-IR signals and the weight fraction of PEI and CS dissolved in acetic
acid.
2.2.4. Determination of the Buffering Capacity of Nanoparticles
The buffering ability of the nanoparticles was observed by recording the pH change
during the titration of acidic nanoparticle dispersion with 0.1 M NaOH solution.
Before titration, 2 ml of the nanoparticle (20 mg/ml) was dispersed in 15 ml of
150 mM NaCl solution, and then the pH of the dispersion was adjusted to 2 with
1.0 M HCl. The 0.1 M NaOH solution was added slowly to the dispersion, and the
pH was recorded as function of the added NaOH solution.
2.2.5. Determination of Amine Groups at the Surface of Nanoparticles
The amount of amine groups on the nanoparticle surface was determined by the
conventional 2,4,6-trinitrobenzene sulfonic acid (TNBS) assay. The nanoparticle
dispersion was diluted to give a final concentration of 10 mg/ml and suspended in
100 µl of phosphate buffered saline solution (10 mM PBS, pH 7.6). Then, 200 µl
of 4% NaHCO3 solution (pH 8.5) and 200 µl of 1% TNBS aqueous solution were
added. These mixtures were incubated at 37◦C for 2 h. After incubation, 200 µl of
the mixtures was added to each well of a 96-well culture plate and the absorbance of
samples was measured at 415 nm using VERSAmax microplate reader (Molecular
Devices, Sunnyvale, CA, USA). The amount of amine groups on the particle surface
was calculated based on the calibration curve prepared by the β-alanine standard
solution.
2.2.6. Preparation of Plasmid DNA
The plasmid DNA was pGL3 vector (5.26 kb), coding for a firefly luciferase gene
(Luciferase Reporter Vectors-pGL3, Promega, Medison, WI, USA). The plasmid
DNA was propagated in an Escherichia coli strain (DH5α) in 1 l LB medium sup-
plemented with 100 µg/ml ampicillin at 37◦C. The mixture was shaken overnight at
210 N. Pimpha et al. / Journal of Biomaterials Science 21 (2010) 205–223
300 rpm. The amplified plasmid DNA was purified using the Qiagen Plasmid Mega
and Giga kit (Qiagen, Tokyo, Japan) according to the manufacturers instructions.
Both yield and purity of the plasmid DNA were evaluated by UV spectrophotome-
try (Ultrospec 2000, Pharmacia, Cambridge, UK) at wavelengths of 260 to 280 nm.
The final concentration was adjusted to be 1 mg/ml.
2.2.7. Complex Formation of Plasmid DNA and CS/PEI Nanoparticles
The complexes were prepared by mixing an aqueous dispersion of nanoparticles
with an aqueous solution of plasmid DNA. Briefty, various amounts of nanopar-
ticles were suspended in 50 µl doubled-deionized water, mixed with 50 µl PBS
containing 100 µg plasmid DNA, and left for 15 min at room temperature to obtain
various complexes. The composition was calculated on the basic of the nitrogen
number of nanoparticles (N) per the phosphorus number of plasmid DNA (P) and
expressed as the N/P ratio. Nitrogen number of nanoparticles was determined us-
ing the TNBS method. The morphology of complexes was observed with SEM. To
prepare the sample, 50 µl complex was dropped on a cover glass and dried in a
dust-free environment. The dried specimens were stuck on the sample holders with
a double-coated carbon conductive tab and then were sputter-coated under vacuum
with platinum and palladium and observed under the microscope at 15 eV.
2.2.8. Gel Retardation Assay
Complexes were prepared in 10 mM PBS solution at different N/P ratios. After
15 min incubation, 7 µl of the complex was added to 3 µl loading buffer solution
(0.1% sodium dodecyl sulfate, 5% glycerol and 0.005% bromophenol blue) and ap-
plied to a 1 wt% agarose gel in tris-borate-ethylenediaminetetraacetic acid buffer
solution (TBE, pH 8.3) containing 0.1 mg/ml of ethidium bromide (EtBr). Elec-
trophoretic evaluation was carried out in TBE solution at 100 V for 30 min. The
gel was imaged with a UV transilluminator (Gel Doc 2000, Bio-Rad Laboratories,
Segrate, Italy).
2.2.9. EtBr Intercalation Assay
A sample containing plasmid DNA (20 µg/ml) and EtBr (0.4 µg /ml) was used
for standard calibration, which was set as 100% fluorescence intensity. MilliQ wa-
ter and EtBr were used as a blank. The nanoparticle dispersion was added to an
aqueous solution of EtBr at different N/P ratios. The fluorescence intensity was
measured at excitation wavelength 510 nm and emission wavelength 590 nm by
using the fluorescent microplate reader (Molecular Devices, Sunnyvale, CA, USA).
The results were expressed as a relative fluorescence intensity (a percentage de-
crease of fluorescence intensity against the fluorescence intensity of the plasmid
DNA–EtBr complex).
2.2.10. Cell Culture
MSCs were isolated from bone shaft of femurs of 3-week-old male Wistar rats.
Both ends of rat femurs were cut away from the epiphysis, and the bone marrow
was flushed out with a syringe (21-gauge needle) with 1 ml minimal essential al-
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pha medium (αMEM) supplemented with 10% fetal bovine serum (FBS). The cell
suspension (5 ml) was placed into two T-25 flasks (Iwaki Glass, Funabashi, Chiba,
Japan) at 37◦C under 5% CO2. The medium was replaced on the fourth day of
culture and every three days thereafter. When the cells of the first passage be-
came sub-confluent, usually within 7–10 days after seeding, the cells were detached
from the flask by treatment with a solution of 0.25 wt% trypsin and 0.02 wt%
ethylenediaminetetraacetic acid (EDTA) in PBS for 5 min at 37◦C. The cells of
second-passage were used for next experimental steps.
2.2.11. In Vitro Gene Transfection Experiment
Transfection experiments were performed independently in triplicate. In a 6-well
plate (Corning, NY, USA), MSCs were seeded at a density of 5 × 104 cells/well
and cultured in 2 ml αMEM-FBS for 24 h. The complexes were formed by mixing
50 µl nanoparticle dispersion in MilliQ water and 50 µl PBS containing 5 µg of
pGL-3-luciferase plasmid DNA at different N/P ratios, followed by incubation for
15 min at room temperature. Immediately after the medium was replaced with fresh
Opti αMEM medium, 100 µl of the complex solution was added and followed by a
6-h incubation for cell transfection. Then, the medium was changed to αMEM-FBS
and cells were incubated further for 24 h. As a positive control, the cells were treated
with the complexes of 250 µl MilliQ water containing 10 µg Lipofectamine™ 2000
(Invitrogen) and 250 µl PBS containing 4 µg pGL-3-luciferase plasmid DNA. Un-
treated cells were assigned as negative control. Then the cells were washed with
PBS and lysed with 200 µl of cell-culture lysis reagent (Promega, Madison, WI,
USA). The cell debris was separated by centrifugation (at 14 × 103 rpm, 20 min).
Then, 100 µl luciferase assay reagent (Promega) was added to 20 µl supernatant.
The relative light unit (RLU) of the samples was determined by a luminometer
(MicroLumatPlus LB 96V, Berthold, Tokyo, Japan). The experiments were pre-
formed in triplicate. The total protein content in each well was determined using
the bicinchonic acid (BCA) protein assay kit (Pierce, Rockford, IL, USA), accord-
ing to the manufacturer instruction in order to normalize the influence of number
variance of cells on the luciferase activity. The gene expression profile at various
post-transfection times (1, 3, 5 and 7 days) was determined. The transfected cells
were cultured in αMEM-FBS at 37◦C under 5% CO2. The medium was replaced
every three days thereafter.
2.2.12. Cell Viability
Cytotoxicity was assayed using a cell counting kit (Nacalai Tesque, Kyoto, Japan).
The cells were seeded at 5×104 cells per well in a 96-well plate using αMEM-FBS,
and incubated at 37◦C for 24 h under a 5% CO2 atmosphere. The medium was re-
placed with Opti αMEM medium, and 10 µl of the complex dispersion was added to
each well and subsequently incubated with the cells for 6 h. The medium was then
replaced with 100 µl fresh αMEM-FBS and 10 µl 2-(2-methoxy-4-nitrophenyl)-3-
(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium (WST-8) solution. The sam-
ples were further incubated at 37◦C for 3 h. The absorbance of samples was mea-
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sured at 450 nm using a VERSAmax microplate reader (Molecular Devices). The
cell viability (%) was calculated according to the following equation:
Cell viability (%) = (Asample/Acontrol) × 100, (1)
where Asample is the absorbance of the complex and Acontrol is the absorbance of
the untreated cells. The results reported were the mean of eight determinations.
2.2.13. Statistical Analysis
All the data were expressed as the mean ± the standard deviation of the mean. Sta-
tistical analysis was performed based on the ANOVA, followed by Fisher’s PLSD
and the significance was accepted at P < 0.05.
3. Results
3.1. Preparation of Nanoparticles
Nanoparticles with a PMMA core and PEI and/or CS shell were prepared by the
emulsifier-free emulsion polymerization. Table 1 summarizes the monomer con-
versions and solid contents of the nanoparticles after polymerization. It can be
observed that the monomer conversions increased with the amount of PEI added
to CS, from 75 to 96%, and the monomer conversion in case of PEI alone was
about 79%. The solid contents of the latexes were in the range of 2.49–4.42%.
3.2. Characterization of Nanoparticles
Table 2 shows the sizes of nanoparticles as determined by the DLS and SEM analy-
ses. PEI nanoparticles had a diameter around 216 nm when measured by the DSL,
but 314 nm from SEM. In the CS/PEI systems, the nanoparticle diameters were in
the range of 129–162 nm (from DSL) and 182–224 nm (from SEM), depending on
the amount of PEI incorporated. The polydispersity index (PDI) of CS nanoparti-
cles was 1.3, while the PDI values of the CS/PEI and PEI nanoparticles were lower,
ranging from 1.17 to 1.25. The surface charges of all nanoparticles were obtained
from zeta-potential measurement (Table 2). The surface charge at pH 7 was found to
Table 1.
Preparation of CS, CS/PEI and PEI nanoparticles with different amounts
of PEI introduced
Sample CS/PEI (w/w) Conversion (%)a Solid content (%)
CS 0.5:0 74.6 ± 2.6 2.40 ± 0.05
CS/PEI 1 0.5:0.1 78.2 ± 2.8 2.87 ± 0.06
CS/PEI 3 0.5:0.3 90.6 ± 5.7 3.72 ± 0.11
CS/PEI 5 0.5:0.5 95.8 ± 7.6 4.42 ± 0.15
PEI 0:0.5 79.3 ± 2.5 3.09 ± 0.05
a Polymerization at 80◦C under N2 atmosphere for 2 h.
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Table 2.
Particle size obtained by DLS and SEM analysis and zeta potential of CS, PEI and CS/PEI nanoparti-
cles with different amounts of PEI introduced
Nanoparticle DLS (nm) SEM (nm) Polydispersitya Zeta potential
(mV)b
CS 162 ± 6.9 182 ± 20 1.30 −3.0 ± 0.2
CS/PEI 1 156 ± 23.7 224 ± 21 1.25 +22.0 ± 0.1
CS/PEI 3 144 ± 19.6 194 ± 20 1.26 +24.0 ± 0.3
CS/PEI 5 129 ± 10 189 ± 20 1.17 +30.5 ± 0.2
PEI 216 ± 39.8 314 ± 24 1.18 +36.8 ± 0.1
a Polydispersity index = Dv/Ds, where Dv is the volume average diameter and Ds the surface
average diameter.
b Determined at pH 7 in 1 mM NaCl solution at room temperature.
increase dramatically from a negative value of CS nanoparticle to positive with PEI
introduction. The PEI nanoparticles exhibited the highest zeta potential at +37 mV.
Figure 2 shows the SEM photographs of nanoparticles. It is apparent that all the
nanoparticles possessed a spherical shape with uniform size distribution. For CS
nanoparticles, the aggregation of nanoparticles was observed. However, when PEI
was added into the system (CS/PEI), the extent of nanoparticle aggregation was
decreased.
Figure 3 shows the FT-IR spectra of grafted products compared to those of chi-
tosan and PEI. The spectrum of 85% deacetylated chitosan (Fig. 3a), showing a
broad peak at 3500–3200 cm−1, was attributed to an O–H stretching (3439 cm−1)
and N–H stretching (3365 cm−1). The peak at 2892 cm−1 corresponded to C–
H stretching vibrations. The characteristic peaks observed at 1649 cm−1 and
1599 cm−1 indicated the amide I (C=O stretching) and amide II (N–H bending),
respectively, due to the remaining acetamide groups in chitosan. However, in the
presence of acetic acid, CS exhibited the two major peaks at 1630 cm−1 (–NH3+
asymmetric deformation) and 1546 cm−1 (–NH3+ complexed with –COO−). The
spectrum of 50 wt% PEI showed the characteristic peaks at 3500–3200 cm−1 (O–
H stretching and N–H stretching), 2949 cm−1 (asymmetric stretching of –CH2),
2847 cm−1 (symmetric stretching of CH2) and 1610 cm−1 (–NH3+ and –NH2+ de-
formation). For the grafted products, their spectra were similar to chitosan and PEI.
Moreover, the additional signal was observed at 1730 cm−1, which corresponded
to the C=O stretching, and indicated the presence of grafted PMMA. However, the
signal of C=O stretching decreased when the amount of PEI increased. This may
be due to the fact that upon increasing the amount of PEI, the shell thickness of
resulted nanoparticles would be increased. This could limit the penetration of the
incident beam on the reflection mode of the FT-IR to the inner layer of the nanopar-
ticles. Therefore, the C=O signal belonging to the grafted PMMA located at the
inner part appeared with the lower intensity when the amount of PEI was increased.
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(a) (b) (c)
(d) (e)
Figure 2. SEM images of nanoparticles. (a) CS, (b) CS/PEI 1, (c) CS/PEI 3, (d) CS/PEI 5 and (e) PEI
at the same magnification.
The weight fraction of PEI introduced to the mixed systems analyzed from the FT-
IR absorption intensity is shown in Table 3. By comparing the intensity of peaks
around 1635 cm−1 (found from both PEI and chitosan) and at 1546 cm−1 (found
in CS only) with the standard calibration curve, the weight fractions of PEI on the
particles were calculated to be 0.45–0.51.
3.3. Determination of Amine Groups at the Nanoparticle Surface Using the TNBS
Assay
Based on the TNBS assay, the amount of free amine groups on the nanoparticle
surfaces can be derived to be 9.43, 19.05, 39.60, 56.75 and 38.06 µmol/ml for CS,
CS/PEI 1, CS/PEI 3, CS/PEI 5 and PEI, respectively.
3.4. Buffering Capacity
Figure 4 shows the change of pH upon titration. For the CS nanoparticles, a rapid
change was observed. The solution pH of CS/PEI nanoparticles changed more
slowly. The higher the amount of PEI introduced, the slower the change of pH
values.
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Figure 3. FT-IR spectra of prepared nanoparticles after Soxhlet extraction. (a) CS powders, (b) PEI
polymer, (c) CS nanoparticles, (d) CS/PEI 1 nanoparticles, (e) CS/PEI 3 nanoparticles, (f) CS/PEI 5
nanoparticles and (g) PEI nanoparticles.
Table 3.
Weight ratios of PEI to CS introduced to nanoparticles
obtained by FT-IR analysis
Nanoparticle (nm) Weight fraction of PEI
In feed In nanoparticles
CS/PEI 1 0.17 0.51
CS/PEI 3 0.38 0.47
CS/PEI 5 0.50 0.45
3.5. Characterization of Nanoparticles–Plasmid DNA Complexes
Figure 5 shows the electrophoretic patterns of nanoparticles–plasmid DNA com-
plexes at different N/P ratios. Migration of plasmid DNA was retarded with an
increase in the N/P ratio. No migration was seen at N/P ratios higher than 0.5. It is
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Figure 4. Titration curves obtained by titrating aqueous solutions of CS (2), CS/PEI 1 (!), CS/PEI 3
(P), CS/PEI 5 (") and PEI (1) nanoparticles in 150 mM aqueous NaCl with 0.1 M NaOH.
apparent from the electrophoresis analysis that the plasmid DNA complexes were
formed at the N/P ratio of 0.5 or higher, irrespective of the nanoparticle type.
Figure 6 shows the nanoparticle–plasmid DNA interaction evaluated by EtBr
intercalation assay. This relative fluorescence of plasmid DNA intercalation with
EtBr was reduced by the addition of nanoparticles as competing components to EtBr
for plasmid DNA binding. It can be seen that the relative fluorescence intensities
for all complexes were lowest at N/P ratios over 0.5.
Table 4 shows the particle size of nanoparticles–plasmid DNA complexes at
N/P = 1.0. The reduction of particle sizes was due to the negatively charged pDNA
partially neutralizing the positively charged chitosan shell.
3.6. Transfection Activity
Figure 7 shows the effect of various nanoparticles on the level of gene expression
for MSC. The level of expression depended on the type of nanoparticle used for
complexation. For every type of nanoparticle, the highest level was observed at the
N/P ratio of 1.0. The level of expression decreased in the order CS/PEI 5, PEI,
CS/PEI 3, CS/PEI 1, Lipofectamine and CS, respectively.
Figure 8 shows that the expression level for the case of Lipofectamine and
PEI nanoparticles decreased rapidly. In contrast, the CS/PEI nanoparticles–plasmid
DNA complexes exhibited gene expression for longer time periods.
3.7. Cytotoxicity Study
Figure 9 shows the viability of MSC 6 h after incubation with the complexes. At
a N/P ratio of 1, where the highest transfection was observed, the cell viability de-




Figure 5. N/P ratios of nanoparticles to plasmid DNA required for complete complexation. (a) CS,
(b) CS/PEI 1, (c) CS/PEI 3, (d) CS/PEI 5 and (e) PEI. Lanes: 1, DNA marker; 2–7, particles/pDNA at
N/P ratios of 0.1, 0.5, 1.0, 1.5, 3.0 and 5.0, respectively.
creased significantly for the PEI nanoparticles, while that of the CS/PEI 1, CS/PEI 3
and CS/PEI 5 did not. The CS/PEI nanoparticles showed lower cytotoxicity com-
pared with the PEI nanoparticles at the corresponding N/P ratio.
4. Discussion
As described in the Materials and methods section, PEI and CS have free amine
groups capable of forming redox pairs with TBHP to generate free radicals on
amine N atoms of PEI and CS. Once the TBHP and NH2 groups of CS and PEI form
a redox pair, the graft co-polymerization of MMA onto CS–PEI is initiated. These
grafted copolymers consisting of hydrophilic CS/PEI and the hydrophobic PMMA
chains, which then spontaneously formed nanoparticles in an aqueous medium. It
is conceivable from the viewpoint of thermodynamics that the hydrophobic seg-
ment is condensed to the central core of nanoparticles, and the hydrophilic segment
is enwrapped the hydrophobic core, resulting in core–shell nanoparticles. These
nanoparticles are stabilized by the positive charges of the CS/PEI shell layer.
The increase of monomer conversion with the amount of PEI introduced is due
to the increasing amount of amine groups. Since the amine groups can form redox
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Figure 6. Relative fluorescence intensity of CS (2), CS/PEI 1 (!), CS/PEI 3 (P), CS/PEI 5 (") and
PEI (1) nanoparticles at different N/P ratios intercalated with EtBr. A sample containing plasmid
DNA (20 µg/ml) and EtBr (0.4 µg/ml) was used for standard calibration, which was set as 100%
fluorescence intensity. MilliQ water and EtBr were used as a blank. The fluorescence intensity was
measured at excitation wavelength 510 nm and emission wavelength 590 nm.
Table 4.
Particle size of original nanoparticles and nanoparticles-
plasmid DNA complexes at N/P = 1.0 obtained by SEM
analysis
Nanoparticle Size (nm)
Before DNA After DNA
complexation complexation
CS 182 ± 20 180 ± 19
CS/PEI 1 224 ± 21 197 ± 22
CS/PEI 3 194 ± 20 186 ± 25
CS/PEI 5 189 ± 20 177 ± 19
PEI 314 ± 24 289 ± 28
pairs with TBHP, with an increase in the amine groups, it is likely that more redox
pairs are formed to generate free radicals. This could accelerate the polymeriza-
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Figure 7. In vitro luciferase transfection expression of Lipofectamine, CS CS/PEI 1, CS/PEI 3, CS/PEI
5 and PEI at different N/P ratios: 0.5 ( ), 1 ( ), 3 ( ), 4 ( ) and 5 ( ) after day 1 post-transfection.
∗P < 0.05, significant against the expression level of Lipofectamine; §P < 0.05, significant against
the expression level of PEI at the corresponding ratio.
tion and result in higher monomer conversion. The solid contents depended on the
amount of CS and PEI introduced, and the monomer conversion percentage.
The introduction of polyethyleneimine to chitosan before emulsion polymeriza-
tion can affect the size of resulted nanoparticles as shown in Table 2. The size of
CS/PEI nanoparticles tended to decrease with the increasing amount of PEI intro-
duced. Since the mechanism in this polymerization system was initiated by free
radicals generated from amine and TBHP. It is possible that the PEI introduction
increased the amine content, resulting in more initiating radicals for polymeriza-
tion. Then the surfactant-like species, which involved in the particle stabilization,
were also increased, resulting in the smaller particle size [24].
The narrow size distribution of nanoparticles would come from the effective nu-
cleation and growth of the nanoparticles in this system. In addition, their presence
on the surface will enable nanoparticles to enhance electrostatic stabilization, which
prevent the growing nanoparticles from aggregation. It can be observed from the
SEM images (Fig. 2) that PEI incorporation gave the nanoparticles a uniform size
distribution.
The increase in the amount of PEI contributes to an increase of amine groups
on the nanoparticle surface. The number of amine groups further increased by the
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Figure 8. In vitro transfection profile of Lipofectamine, PEI, CS/PEI 1, CS/PEI 3 and CS/PEI 5 after
days 1 ( ), 3 ( ), 5 ( ) and 7 ( ) post-transfection. ∗P < 0.05, significant against the expression
level of Lipofectamine; §P < 0.05, significant against the expression level of PEI at the corresponding
post-transfection.
addition of PEI on the nanoparticle surfaces. In acidic conditions, the nanoparticle
surface is of positive charge because the amine groups of PEI and chitosan on the
nanoparticle surface are protonated. The surface charge would enable the nanopar-
ticles to homogeneously disperse in the aqueous medium through an electrostatic
repulsion force. The positive character contributed to the high capability to complex
electrostatically with negatively charged plasmid DNA.
It is known that the buffering effect of PEI facilitates endosomal escape [18].
In this study, this property was observed in the PEI-incorporated nanoparticles as
well. In Fig. 4, the buffering effect of PEI nanoparticles is demonstated by a slow
change of pH of solution. In contrast, the solution pH of CS nanoparticles showed a
rapid change. Upon increasing the amount of PEI in the CS/PEI systems, the change
was retarded. This retardation of pH change would mainly be due to the buffering
effect of PEI, and this effect can be observed even in the form of nanoparticles.
In addition, the buffering effect of nanoparticles was found to be affected by the
PEI incorporation. This clearly indicates that PEI present in the surface of CS/PEI
nanoparticles can maintain its buffering ability.
Electrophoretic results indicated that the nanoparticles could form a complex
with the plasmid DNA at N/P ratios of 0.5 or higher, which corresponded well to
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Figure 9. The cell viability of rMSCs transfected with CS/PEI nanoparticle–plasmid DNA complexes
prepared at different N/P ratios: 0.5 ( ), 1 ( ), 3 ( ) and 5 ( ). ∗P < 0.05, significant against the
relative cell viability of PEI at the corresponding ratio.
the result of the EtBr intercalation assay. When comparing the retardation rate be-
tween various nanoparticles prepared at N/P ratios of 0.5–1.0, the CS nanoparticles
showed the lowest rate, while the PEI and CS/PEI showed a similar profile. It is
likely that the PEI and CS/PEI nanopartcles rapidly formed a complex with the
plasmid DNA because the large number of positive amine groups on the surface
causes stronger electrostatic interaction with the plasmid DNA, as evidenced by the
reduction of complex size.
In general, PEI has been revealed to be a most effective non-viral vector due to
its high pH buffering capacity, providing high concentration of protanable amine
and imine groups, which are believed to enhance the release of carriers from the
endosomal compartment [18, 21]. However, PEI has a major drawback on its toxi-
city that can limit the application in gene therapy. In contrast, the low transfection
efficiency of chitosan was agreed with several works [20, 22, 25]. This limitation
was caused by the inefficient endosomal escape [25]. It has been reported that the
ability for complexes to escape the endosomal compartment can be correlated to
the buffering capacity of the polymer [26, 27]. Therefore, in order to improve the
transfection efficiency, modification of chitosan is of great consideration.
In this study, the combination of high transfection ability of PEI and biocom-
patibility of CS was attempted. The gene transfection for a superior transfection
efficiency was observed compared with commercially available Lipofectamine, as
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expected. The in vitro gene expression of plasmid DNA was greatly enhanced by
the introduction of PEI to CS nanoparticles. Also, the amount of PEI incorpo-
rated showed significant influence. This high efficiency of CS/PEI may be due
to the presence of PEI. The PEI has enhanced buffering capacity in the endoso-
mal compartment of cells. The rapid gene expression induction of PEI attributed
to a fast endosomal escape, which was correlated with the results of Artursson and
co-workers [19]. Its high efficiency may also be due to the enhancement of gene
transportation from the cytoplasm to the nucleus. In addition, the highest expres-
sion for CS/PEI 5 might be due to the lower toxicity of CS/PEI 5 comparing with
PEI itself.
It can be seen from the results that CS/PEI nanoparticles showed the high trans-
fection efficiency and prolonged gene expression. It was hypothesized that the
CS/PEI nanoparticles have less toxicity as indicated by the high percentage of cell
viability. A more detailed investigation is under way.
It is also known that the cause of PEI cytotoxicity may be due to the multiple
attachment of PEI to the cell surface, resulting in lysis of the cell [28]. In case of
the CS/PEI, although PEI was combined in the particles, the cell viability was still
high at the corresponding N/P ratio. However, the decrease in relative cell viability
was related with the amount of PEI incorporated as well as the increase of N/P ratio.
The existence of CS could lower the cytotoxicity of the particles, if the PEI content
is low. In addition, it is possible that this low cytotoxicity gives rise to enhanced
gene transfection and prolonged expression.
5. Conclusion
PEI-introduced CS nanoparticles showed promising particle size, dispersity, surface
charge and buffering capacity, from the viewpoint of gene transfection carrier. Gene
transfection of CS/PEI nanoparticles for MSCs was achieved with an efficiency
higher than that of chitosan and Lipofectamine. It is possible that the increase in
amine groups from PEI leads to the enhanced buffering ability in the endosomal
compartment. CS/PEI 5 exhibited a higher transfection ability than the original PEI
and, additionally, lower toxicity. It can be concluded that the combination of chi-
tosan and PEI on the nanoparticles is promising as gene-delivery carriers for MSCs.
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